These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31590726)

  • 1. Dopamine and the motivation of cognitive control.
    Cools R; Froböse M; Aarts E; Hofmans L
    Handb Clin Neurol; 2019; 163():123-143. PubMed ID: 31590726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine restores cognitive motivation in Parkinson's disease.
    McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
    Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs and benefits of brain dopamine for cognitive control.
    Cools R
    Wiley Interdiscip Rev Cogn Sci; 2016 Sep; 7(5):317-29. PubMed ID: 27507774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopamine in the motivational and cognitive control of behavior.
    Cools R
    Neuroscientist; 2008 Aug; 14(4):381-95. PubMed ID: 18660464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine.
    Aarts E; van Holstein M; Hoogman M; Onnink M; Kan C; Franke B; Buitelaar J; Cools R
    Behav Pharmacol; 2015 Feb; 26(1-2):227-40. PubMed ID: 25485641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.
    Bogdanov M; LoParco S; Otto AR; Sharp M
    Neurobiol Learn Mem; 2022 Sep; 193():107652. PubMed ID: 35724812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverted-U-shaped dopamine actions on human working memory and cognitive control.
    Cools R; D'Esposito M
    Biol Psychiatry; 2011 Jun; 69(12):e113-25. PubMed ID: 21531388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.
    Admon R; Kaiser RH; Dillon DG; Beltzer M; Goer F; Olson DP; Vitaliano G; Pizzagalli DA
    Am J Psychiatry; 2017 Apr; 174(4):378-386. PubMed ID: 27771973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility.
    Berry AS; Shah VD; Baker SL; Vogel JW; O'Neil JP; Janabi M; Schwimmer HD; Marks SM; Jagust WJ
    J Neurosci; 2016 Dec; 36(50):12559-12569. PubMed ID: 27807030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
    Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
    Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic inhibition of neurotransmission reveals role of glutamatergic input to dopamine neurons in high-effort behavior.
    Hutchison MA; Gu X; Adrover MF; Lee MR; Hnasko TS; Alvarez VA; Lu W
    Mol Psychiatry; 2018 May; 23(5):1213-1225. PubMed ID: 28194005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromodulation of Prefrontal Cortex in Non-Human Primates by Dopaminergic Receptors during Rule-Guided Flexible Behavior and Cognitive Control.
    Vijayraghavan S; Major AJ; Everling S
    Front Neural Circuits; 2017; 11():91. PubMed ID: 29259545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating neurotransmission in striatal medium spiny neurons.
    Girault JA
    Adv Exp Med Biol; 2012; 970():407-29. PubMed ID: 22351066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.
    Kulisevsky J
    Drugs Aging; 2000 May; 16(5):365-79. PubMed ID: 10917074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine: a key regulator to adapt action, emotion, motivation and cognition.
    Nieoullon A; Coquerel A
    Curr Opin Neurol; 2003 Dec; 16 Suppl 2():S3-9. PubMed ID: 15129844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Does Double Duty in Motivating Cognitive Effort.
    Westbrook A; Braver TS
    Neuron; 2016 Feb; 89(4):695-710. PubMed ID: 26889810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional mapping of dopaminergic transmission].
    Sawamoto N
    Rinsho Shinkeigaku; 2007 Nov; 47(11):832-4. PubMed ID: 18210810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.